Atrium Therapeutics announces its Q3 results, showcasing its focus on pharmaceutical preparations and partnerships with industry leaders.
| Name | Atrium Therapeutics, Inc. |
|---|---|
| CIK | 0002093101 |
| Tickers | RNA |
| Exchanges | Nasdaq |
| Entity type | operating |
| Category | Non-accelerated filer<br>Smaller reporting company<br>Emerging growth company |
| SIC | 2834 Pharmaceutical Preparations |
| EIN | 394639499 |
| LEI | — |
| Fiscal year end | 1231 |
| State of incorporation | — |
| Phone | 6198760700 |
| Website | — |
| Investor website | — |
| Owner org | 03 Life Sciences |
| Flags | — |
| Description | — |
| Insider transactions (issuer) | 1 |
| Insider transactions (owner) | 0 |
EDGAR has no company-logo API. Website field is shown when the filer provided one.
Atrium Therapeutics announces its Q3 results, showcasing its focus on pharmaceutical preparations and partnerships with industry leaders.
Atrium Therapeutics reveals new nonclinical data for ATR 1072, targeting PRKAG2 syndrome, ahead of its presentation at the AHA Scientific Sessions 2026.
Atrium Therapeutics has begun dosing in its Phase 1/2 trial of ATR 1072, targeting PRKAG2 syndrome, marking a significant milestone in genetic cardiomyopathy treatment.
Atrium Therapeutics corrects its share count in an SEC filing following a recent securities offering, ensuring transparency for investors.
Atrium Therapeutics has entered a securities purchase agreement to raise $50 million, enhancing its funding for product development and research.
61 filing rows loaded from submissions recent.
| Filed | Form | Document | Items | Accession | File no. | Film | Act | Size | XBRL | iXBRL |
|---|---|---|---|---|---|---|---|---|---|---|
| 2026-11-16 | SCHEDULE 13G/A | xslSCHEDULE_13G_X02/primary_doc.xml | 0000080255-26-000732 | 005-95606 | 261556471 | 34 | 7775 | |||
| 2026-11-12 | 10-Q | 10-Q | 0001193125-26-458471 | 001-43008 | 261547276 | 34 | 13590184 | 1 | 1 | |
| 2026-11-12 | 8-K | 8-K | 2.02,9.01 | 0001193125-26-458459 | 001-43008 | 261547198 | 34 | 252368 | 1 | 1 |
| 2026-11-02 | 8-K | 8-K | 7.01,8.01,9.01 | 0001193125-26-442601 | 001-43008 | 261509842 | 34 | 13397478 | 1 | 1 |
| 2026-10-27 | 8-K | 8-K | 8.01,9.01 | 0001193125-26-432949 | 001-43008 | 261487701 | 34 | 182835 | 1 | 1 |
| 2026-10-09 | 8-K/A | 8-K/A | 8.01 | 0001193125-26-418417 | 001-43008 | 261451106 | 34 | 146257 | 1 | 1 |
| 2026-10-08 | 8-K | 8-K | 1.01,3.02,8.01,9.01 | 0001193125-26-417402 | 001-43008 | 261448278 | 34 | 685421 | 1 | 1 |
| 2026-09-22 | 4 | 4 | 0001193125-26-397971 | 4850 | ||||||
| 2026-09-22 | 4 | 4 | 0001193125-26-397967 | 4884 | ||||||
| 2026-09-22 | 4 | 4 | 0001193125-26-397955 | 4817 | ||||||
| 2026-09-22 | 4 | 4 | 0001193125-26-397951 | 4805 | ||||||
| 2026-09-22 | 4 | 4 | 0001193125-26-397948 | 4900 | ||||||
| 2026-09-22 | 4 | 4 | 0001193125-26-397944 | 4938 | ||||||
| 2026-09-22 | 4 | 4 | 0001193125-26-397941 | 4842 | ||||||
| 2026-09-22 | 4 | 4 | 0001193125-26-397936 | 4859 | ||||||
| 2026-08-14 | SCHEDULE 13G/A | xslSCHEDULE_13G_X02/primary_doc.xml | 0001231919-26-000917 | 005-95606 | 261282879 | 34 | 12332 | |||
| 2026-08-14 | SCHEDULE 13G | xslSCHEDULE_13G_X02/primary_doc.xml | 0000902664-26-003500 | 005-95606 | 261281444 | 34 | 14130 | |||
| 2026-08-14 | SCHEDULE 13G/A | xslSCHEDULE_13G_X02/primary_doc.xml | 0000080255-26-000590 | 005-95606 | 261277451 | 34 | 7723 | |||
| 2026-08-13 | 10-Q | 10-Q | 0001193125-26-349488 | 001-43008 | 261274563 | 34 | 7665862 | 1 | 1 | |
| 2026-08-13 | 8-K | 8-K | 2.02,9.01 | 0001193125-26-349482 | 001-43008 | 261274543 | 34 | 241495 | 1 | 1 |
| 2026-07-27 | SCHEDULE 13G/A | xslSCHEDULE_13G_X02/primary_doc.xml | 0002012383-26-002192 | 005-95606 | 261206031 | 34 | 10966 | |||
| 2026-07-14 | 8-K | 8-K | 8.01,9.01 | 0001193125-26-303393 | 001-43008 | 261175022 | 34 | 164592 | 1 | 1 |
| 2026-05-15 | SCHEDULE 13G | xslSCHEDULE_13G_X02/primary_doc.xml | 0001346824-26-000145 | 005-95606 | 26988626 | 34 | 18393 | |||
| 2026-05-14 | 10-Q | 10-Q | 0001193125-26-224243 | 001-43008 | 26980021 | 34 | 5906905 | 1 | 1 | |
| 2026-05-14 | 8-K | 8-K | 2.02,9.01 | 0001193125-26-224238 | 001-43008 | 26979999 | 34 | 225728 | 1 | 1 |
| 2026-04-27 | SCHEDULE 13G | xslSCHEDULE_13G_X02/primary_doc.xml | 0002012383-26-001673 | 005-95606 | 26901038 | 34 | 10907 | |||
| 2026-04-22 | 4 | 4 | 0001193125-26-170964 | 7611 | ||||||
| 2026-04-22 | 4 | 4 | 0001193125-26-170963 | 7596 | ||||||
| 2026-04-22 | 4 | 4 | 0001193125-26-170960 | 7553 | ||||||
| 2026-04-22 | 4 | 4 | 0001193125-26-170914 | 7652 | ||||||
| 2026-04-22 | 4 | 4 | 0001193125-26-170907 | 7570 | ||||||
| 2026-04-22 | 4 | 4 | 0001193125-26-170906 | 7561 | ||||||
| 2026-04-17 | S-8 | S-8 | 0001193125-26-161513 | 333-295136 | 26871530 | 33 | 372367 | 1 | 1 | |
| 2026-04-08 | SCHEDULE 13G | xslSCHEDULE_13G_X02/primary_doc.xml | 0000080255-26-000316 | 005-95606 | 26847843 | 34 | 7557 | |||
| 2026-03-02 | 4 | 4 | 0001193125-26-085922 | 5388 | ||||||
| 2026-03-02 | 4 | 4 | 0001193125-26-085921 | 5392 | ||||||
| 2026-03-02 | 4 | 4 | 0001193125-26-085920 | 5390 | ||||||
| 2026-03-02 | 4 | 4 | 0001193125-26-085919 | 5402 | ||||||
| 2026-03-02 | 4 | 4 | 0001193125-26-085918 | 5398 | ||||||
| 2026-02-27 | 8-K | 8-K | 1.01,5.01,5.02,9.01 | 0001193125-26-083227 | 001-43008 | 26701936 | 34 | 909934 | 1 | 1 |
| 2026-02-26 | 3 | 3 | 0001193125-26-077934 | 20033 | ||||||
| 2026-02-26 | 3 | 3 | 0001193125-26-077907 | 19423 | ||||||
| 2026-02-26 | 3 | 3 | 0001193125-26-077801 | 19141 | ||||||
| 2026-02-26 | 3 | 3 | 0001193125-26-077764 | 18498 | ||||||
| 2026-02-26 | 3 | 3 | 0001193125-26-077763 | 19102 | ||||||
| 2026-02-26 | 3 | 3 | 0001193125-26-077740 | 18624 | ||||||
| 2026-02-26 | 3 | 3 | 0001193125-26-077739 | 19918 | ||||||
| 2026-02-26 | 3 | 3 | 0001193125-26-077733 | 18902 | ||||||
| 2026-02-26 | 3 | 3 | 0001193125-26-077728 | 19120 | ||||||
| 2026-02-26 | 3 | 3 | 0001193125-26-077718 | 19186 | ||||||
| 2026-02-26 | 3 | 3 | 0001193125-26-077716 | 19172 | ||||||
| 2026-02-26 | 8-K | 8-K | 7.01,9.01 | 0001193125-26-077105 | 001-43008 | 26690044 | 34 | 3302432 | 1 | 1 |
| 2026-02-26 | S-8 | S-8 | 0001193125-26-075072 | 333-293782 | 26684452 | 33 | 519203 | 1 | 1 | |
| 2026-02-26 | SEC STAFF ACTION | filename1.pdf | 9999999997-26-000345 | 4161 | ||||||
| 2026-02-26 | CERT | RNA_Form10_Cert_2093101.pdf | 0001354457-26-000219 | 001-43008 | 26682764 | 34 | 591686 | |||
| 2026-02-24 | CORRESP | filename1.htm | 0001193125-26-066190 | 10680 | ||||||
| 2026-02-17 | 10-12B/A | 10-12B/A | 0001193125-26-055010 | 001-43008 | 26643241 | 34 | 6596871 | |||
| 2026-01-30 | 10-12B/A | 10-12B/A | 0001193125-26-029976 | 001-43008 | 26580239 | 34 | 5658203 | |||
| 2026-01-29 | CORRESP | filename1.htm | 0001193125-26-029980 | 25114 | ||||||
| 2026-01-27 | UPLOAD | filename1.pdf | 0000000000-26-000898 | 001-43008 | 50241 | |||||
| 2025-12-10 | 10-12B | 10-12B | 0001193125-25-314415 | 001-43008 | 251562773 | 34 | 3280709 |
One latest value per concept from companyfacts (110 concepts). Full history stays in the JSON.
| Taxonomy | Tag | Label | Unit | Value | Start | End | FY | FP | Form | Filed | Accn |
|---|---|---|---|---|---|---|---|---|---|---|---|
| dei | EntityCommonStockSharesOutstanding | Entity Common Stock, Shares Outstanding | shares | 21.57M | 2026-11-02 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-458471 | |
| ffd | NetFeeAmt | NetFeeAmt | USD | 607.92 | 2026-04-16 | S-8 | 2026-04-17 | 0001193125-26-161513 | |||
| ffd | TtlFeeAmt | TtlFeeAmt | USD | 607.92 | 2026-04-16 | S-8 | 2026-04-17 | 0001193125-26-161513 | |||
| ffd | TtlOfferingAmt | TtlOfferingAmt | USD | 4.40M | 2026-04-16 | S-8 | 2026-04-17 | 0001193125-26-161513 | |||
| ffd | TtlOffsetAmt | TtlOffsetAmt | USD | 0 | 2026-04-16 | S-8 | 2026-04-17 | 0001193125-26-161513 | |||
| us-gaap | AccountsPayableCurrent | Accounts Payable, Current | USD | 782,000 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-458471 | |
| us-gaap | AccretionAmortizationOfDiscountsAndPremiumsInvestments | Accretion (Amortization) of Discounts and Premiums, Investments | USD | 625,000 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-458471 |
| us-gaap | AccruedLiabilitiesCurrent | Accrued Liabilities, Current | USD | 8.70M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-458471 | |
| us-gaap | AccumulatedOtherComprehensiveIncomeLossNetOfTax | Accumulated Other Comprehensive Income (Loss), Net of Tax | USD | -347,000 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-458471 | |
| us-gaap | AdditionalPaidInCapital | Additional Paid in Capital | USD | 217.67M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-458471 | |
| us-gaap | AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation | Share-based Payment Arrangement, Decrease for Tax Withholding Obligation | USD | 6.30M | 2026-07-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-458471 |
| us-gaap | AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue | APIC, Share-based Payment Arrangement, Increase for Cost Recognition | USD | 1.13M | 2026-07-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-458471 |
| us-gaap | AllocatedShareBasedCompensationExpense | Share-based Payment Arrangement, Expense | USD | 14.23M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-458471 |
| us-gaap | AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount | shares | 1.40M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-458471 |
| us-gaap | Assets | Assets | USD | 263.99M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-458471 | |
| us-gaap | AssetsCurrent | Assets, Current | USD | 258.05M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-458471 | |
| us-gaap | AssetsFairValueDisclosure | Assets, Fair Value Disclosure | USD | 230.57M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-458471 | |
| us-gaap | AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax | Debt Securities, Available-for-sale, Accumulated Gross Unrealized Gain, before Tax | USD | 0 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-458471 | |
| us-gaap | AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax | Debt Securities, Available-for-sale, Accumulated Gross Unrealized Loss, before Tax | USD | 347,000 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-458471 | |
| us-gaap | CapitalExpendituresIncurredButNotYetPaid | Capital Expenditures Incurred but Not yet Paid | USD | 0 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-458471 |
| us-gaap | Cash | Cash | USD | 270.00M | 2026-02-26 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-458471 | |
| us-gaap | CashAndCashEquivalentsAtCarryingValue | Cash and Cash Equivalents, at Carrying Value | USD | 44.56M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-458471 | |
| us-gaap | CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents | USD | 44.98M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-458471 | |
| us-gaap | CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect | USD | 44.98M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-458471 |
| us-gaap | CommonStockParOrStatedValuePerShare | Common Stock, Par or Stated Value Per Share | USD/shares | 0.001 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-458471 | |
| us-gaap | CommonStockSharesAuthorized | Common Stock, Shares Authorized | shares | 400.00M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-458471 | |
| us-gaap | CommonStockSharesIssued | Common Stock, Shares, Issued | shares | 16.40M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-458471 | |
| us-gaap | CommonStockSharesOutstanding | Common Stock, Shares, Outstanding | shares | 16.40M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-458471 | |
| us-gaap | CommonStockValue | Common Stock, Value, Issued | USD | 16,000 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-458471 | |
| us-gaap | ComprehensiveIncomeNetOfTax | Comprehensive Income (Loss), Net of Tax, Attributable to Parent | USD | -41.43M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-458471 |
| us-gaap | ContractWithCustomerLiability | Contract with Customer, Liability | USD | 42.37M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-458471 | |
| us-gaap | ContractWithCustomerLiabilityCurrent | Contract with Customer, Liability, Current | USD | 9.45M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-458471 | |
| us-gaap | ContractWithCustomerLiabilityNoncurrent | Contract with Customer, Liability, Noncurrent | USD | 32.92M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-458471 | |
| us-gaap | ContractWithCustomerLiabilityRevenueRecognized | Contract with Customer, Liability, Revenue Recognized | USD | 321,000 | 2026-07-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-458471 |
| us-gaap | DebtSecuritiesAvailableForSaleAccruedInterestAfterAllowanceForCreditLoss | Debt Securities, Available-for-Sale, Accrued Interest, after Allowance for Credit Loss | USD | 1.60M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-458471 | |
| us-gaap | DebtSecuritiesAvailableForSaleAccruedInterestWriteoff | Debt Securities, Available-for-Sale, Accrued Interest Writeoff | USD | 0 | 2026-01-01 | 2026-06-30 | 2026 | Q2 | 10-Q | 2026-08-13 | 0001193125-26-349488 |
| us-gaap | DebtSecuritiesAvailableForSaleAmortizedCostAllowanceForCreditLossExcludingAccruedInterest | DebtSecuritiesAvailableForSaleAmortizedCostAllowanceForCreditLossExcludingAccruedInterest | USD | 0 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-458471 | |
| us-gaap | DebtSecuritiesAvailableForSaleAmortizedCostExcludingAccruedInterestAfterAllowanceForCreditLoss | DebtSecuritiesAvailableForSaleAmortizedCostExcludingAccruedInterestAfterAllowanceForCreditLoss | USD | 187.86M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-458471 | |
| us-gaap | DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months | Debt Securities, Available-for-sale, Continuous Unrealized Loss Position, Less than 12 Months | USD | 187.51M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-458471 | |
| us-gaap | DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss | Debt Securities, Available-for-sale, Continuous Unrealized Loss Position, Less than 12 Months, Accumulated Loss | USD | 347,000 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-458471 | |
| us-gaap | DebtSecuritiesAvailableForSaleExcludingAccruedInterest | DebtSecuritiesAvailableForSaleExcludingAccruedInterest | USD | 187.51M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-458471 | |
| us-gaap | DebtSecuritiesAvailableForSaleUnrealizedLossPosition | Debt Securities, Available-for-sale, Unrealized Loss Position | USD | 187.51M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-458471 | |
| us-gaap | DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss | Debt Securities, Available-for-sale, Unrealized Loss Position, Accumulated Loss | USD | 347,000 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-458471 | |
| us-gaap | Depreciation | Depreciation | USD | 846,000 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-458471 |
| us-gaap | EarningsPerShareBasic | Earnings Per Share, Basic | USD/shares | -2.41 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-458471 |
| us-gaap | EarningsPerShareDiluted | Earnings Per Share, Diluted | USD/shares | -2.41 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-458471 |
| us-gaap | FairValueOfAssetsAcquired | Fair Value of Assets Acquired | USD | 0 | 2026-01-01 | 2026-06-30 | 2026 | Q2 | 10-Q | 2026-08-13 | 0001193125-26-349488 |
| us-gaap | GainLossOnDispositionOfAssets | Gain (Loss) on Disposition of Property Plant Equipment, Excluding Oil and Gas Property and Timber Property | USD | 61,000 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-458471 |
| us-gaap | GeneralAndAdministrativeExpense | General and Administrative Expense | USD | 38.69M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-458471 |
| us-gaap | IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest | Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest | USD | -41.09M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-458471 |
| us-gaap | IncomeTaxExpenseBenefit | Income Tax Expense (Benefit) | USD | 0 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-458471 |
| us-gaap | IncreaseDecreaseInAccountsPayable | Increase (Decrease) in Accounts Payable | USD | -3.62M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-458471 |
| us-gaap | IncreaseDecreaseInAccountsReceivable | Increase (Decrease) in Accounts Receivable | USD | 15.00M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-458471 |
| us-gaap | IncreaseDecreaseInAccruedLiabilities | Increase (Decrease) in Accrued Liabilities | USD | -275,000 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-458471 |
| us-gaap | IncreaseDecreaseInContractWithCustomerLiability | Increase (Decrease) in Contract with Customer, Liability | USD | -7.96M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-458471 |
| us-gaap | IncreaseDecreaseInEmployeeRelatedLiabilities | Increase (Decrease) in Employee Related Liabilities | USD | 1.91M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-458471 |
| us-gaap | IncreaseDecreaseInOperatingLeaseLiability | IncreaseDecreaseInOperatingLeaseLiability | USD | -3.03M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-458471 |
| us-gaap | IncreaseDecreaseInOtherCurrentAssets | Increase (Decrease) in Other Current Assets | USD | 819,000 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-458471 |
| us-gaap | IncreaseDecreaseInOtherNoncurrentAssets | Increase (Decrease) in Other Noncurrent Assets | USD | 1.12M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-458471 |
| us-gaap | IncreaseDecreaseInOtherNoncurrentLiabilities | Increase (Decrease) in Other Noncurrent Liabilities | USD | 807,000 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-458471 |
| us-gaap | IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets | Increase (Decrease) in Prepaid Expense and Other Assets | USD | 7.00M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-458471 |
| us-gaap | InterestIncomeOther | Interest Income, Other | USD | 4.94M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-458471 |
| us-gaap | Liabilities | Liabilities | USD | 58.97M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-458471 | |
| us-gaap | LiabilitiesAndStockholdersEquity | Liabilities and Equity | USD | 263.99M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-458471 | |
| us-gaap | LiabilitiesCurrent | Liabilities, Current | USD | 24.66M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-458471 | |
| us-gaap | NetAssetValuePerShare | Net Asset Value Per Share | USD/shares | 1 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-458471 | |
| us-gaap | NetCashProvidedByUsedInFinancingActivities | Net Cash Provided by (Used in) Financing Activities | USD | 295.20M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-458471 |
| us-gaap | NetCashProvidedByUsedInInvestingActivities | Net Cash Provided by (Used in) Investing Activities | USD | -189.78M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-458471 |
| us-gaap | NetCashProvidedByUsedInOperatingActivities | Net Cash Provided by (Used in) Operating Activities | USD | -60.44M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-458471 |
| us-gaap | NetIncomeLoss | Net Income (Loss) Attributable to Parent | USD | -41.09M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-458471 |
| us-gaap | NoncashOrPartNoncashAcquisitionFixedAssetsAcquired1 | Noncash or Part Noncash Acquisition, Fixed Assets Acquired | USD | 103,000 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-458471 |
| us-gaap | NonoperatingIncomeExpense | Nonoperating Income (Expense) | USD | 5.44M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-458471 |
| us-gaap | NumberOfOperatingSegments | Number of Operating Segments | Segment | 1 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-458471 |
| us-gaap | NumberOfReportableSegments | Number of Reportable Segments | Segment | 1 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-458471 |
| us-gaap | OperatingExpenses | Operating Expenses | USD | 84.49M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-458471 |
| us-gaap | OperatingIncomeLoss | Operating Income (Loss) | USD | -46.53M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-458471 |
| us-gaap | OperatingLeaseLiabilityCurrent | Operating Lease, Liability, Current | USD | 679,000 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-458471 | |
| us-gaap | OperatingLeaseRightOfUseAsset | Operating Lease, Right-of-Use Asset | USD | 520,000 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-458471 | |
| us-gaap | OperatingLeaseRightOfUseAssetAmortizationExpense | Operating Lease, Right-of-Use Asset, Amortization Expense | USD | 2.36M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-458471 |
| us-gaap | OtherAccruedLiabilitiesCurrent | Other Accrued Liabilities, Current | USD | 1.98M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-458471 | |
| us-gaap | OtherAssetsCurrent | Other Assets, Current | USD | 2.13M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-458471 | |
| us-gaap | OtherAssetsNoncurrent | Other Assets, Noncurrent | USD | 1.12M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-458471 | |
| us-gaap | OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax | OCI, Debt Securities, Available-for-Sale, Gain (Loss), after Adjustment and Tax | USD | -347,000 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-458471 |
| us-gaap | OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax | OCI, Debt Securities, Available-for-Sale, Unrealized Holding Gain (Loss), before Adjustment, after Tax | USD | -112,000 | 2026-07-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-458471 |
| us-gaap | OtherLiabilitiesNoncurrent | Other Liabilities, Noncurrent | USD | 1.38M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-458471 | |
| us-gaap | OtherNonoperatingIncomeExpense | Other Nonoperating Income (Expense) | USD | 499,000 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-458471 |
| us-gaap | PaymentsRelatedToTaxWithholdingForShareBasedCompensation | Payment, Tax Withholding, Share-based Payment Arrangement | USD | 6.30M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-458471 |
| us-gaap | PaymentsToAcquireAvailableForSaleSecuritiesDebt | Payments to Acquire Debt Securities, Available-for-sale | USD | 230.23M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-458471 |
| us-gaap | PaymentsToAcquirePropertyPlantAndEquipment | Payments to Acquire Property, Plant, and Equipment | USD | 2.55M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-458471 |
| us-gaap | PreferredStockParOrStatedValuePerShare | Preferred Stock, Par or Stated Value Per Share | USD/shares | 0.001 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-458471 | |
| us-gaap | PreferredStockSharesAuthorized | Preferred Stock, Shares Authorized | shares | 40.00M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-458471 | |
| us-gaap | PreferredStockSharesIssued | Preferred Stock, Shares Issued | shares | 0 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-458471 | |
| us-gaap | PreferredStockSharesOutstanding | Preferred Stock, Shares Outstanding | shares | 0 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-458471 | |
| us-gaap | PrepaidExpenseCurrent | Prepaid Expense, Current | USD | 8.54M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-458471 | |
| us-gaap | ProceedsFromContributionsFromAffiliates | Proceeds from Contributions from Affiliates | USD | 301.50M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-458471 |
| us-gaap | ProceedsFromSaleOfAvailableForSaleSecuritiesDebt | Proceeds from Sale of Debt Securities, Available-for-sale | USD | 43.00M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-458471 |
| us-gaap | ProfitLoss | Net Income (Loss), Including Portion Attributable to Noncontrolling Interest | USD | -41.09M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-458471 |
| us-gaap | PropertyPlantAndEquipmentNet | Property, Plant and Equipment, Net | USD | 4.19M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-458471 | |
| us-gaap | ResearchAndDevelopmentExpense | Research and Development Expense | USD | 45.80M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-458471 |
| us-gaap | RestrictedCashCurrent | Restricted Cash, Current | USD | 312,000 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-458471 | |
| us-gaap | RestrictedCashNoncurrent | Restricted Cash, Noncurrent | USD | 106,000 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-458471 | |
| us-gaap | RetainedEarningsAccumulatedDeficit | Retained Earnings (Accumulated Deficit) | USD | -12.32M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-458471 | |
| us-gaap | RevenueFromContractWithCustomerExcludingAssessedTax | Revenue from Contract with Customer, Excluding Assessed Tax | USD | 37.96M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-458471 |
| us-gaap | ShareBasedCompensation | Share-based Payment Arrangement, Noncash Expense | USD | 14.23M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-458471 |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod | Share-based Compensation Arrangement by Share-based Payment Award, Shares Issued in Period | shares | 0 | 2026-02-26 | 2026-03-31 | 2026 | Q1 | 10-Q | 2026-05-14 | 0001193125-26-224243 |
| us-gaap | SharesPaidForTaxWithholdingForShareBasedCompensation | Share-based Payment Arrangement, Shares Withheld for Tax Withholding Obligation | shares | 704,520 | 2026-09-18 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-458471 | |
| us-gaap | ShortTermInvestments | Short-term Investments | USD | 187.51M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-458471 | |
| us-gaap | StockholdersEquity | Stockholders' Equity Attributable to Parent | USD | 205.02M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-458471 | |
| us-gaap | WeightedAverageNumberOfDilutedSharesOutstanding | Weighted Average Number of Shares Outstanding, Diluted | shares | 17.08M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-458471 |
| us-gaap | WeightedAverageNumberOfSharesOutstandingBasic | Weighted Average Number of Shares Outstanding, Basic | shares | 17.08M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-458471 |